ImmunityBio
IBRX
IBRX
146 hedge funds and large institutions have $292M invested in ImmunityBio in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 28 reducing their positions, and 13 closing their positions.
Holders
146
Holders Change
+16
Holders Change %
+12.31%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
30
Increased
57
Reduced
28
Closed
13
Calls
$14.5M
Puts
$5.13M
Net Calls
+$9.38M
Net Calls Change
+$9.57M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$47.5M |
| 2 |
2
Goldman Sachs
New York
|
$6.42M |
| 3 |
3
Jane Street
New York
|
$4.12M |
| 4 |
4
Morgan Stanley
New York
|
$6.02M |
| 5 |
5
Rafferty Asset Management
New York
|
$3.71M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Point72 Asset Management
Stamford,
Connecticut
| – | -$26.2K | -15,500 | Closed |
|
|
WG
152
Winton Group
London,
United Kingdom
| – | -$26.1K | -15,438 | Closed |
|
|
EGM
153
Engineers Gate Manager
New York
| – | -$23K | -13,632 | Closed |
|
|
MAWA
154
Moss Adams Wealth Advisors
Seattle,
Washington
| – | -$20.9K | -12,341 | Closed |
|
|
SPC
155
Sigma Planning Corp
Ann Arbor,
Michigan
| – | -$18.7K | -11,050 | Closed |
|
156
US Bancorp
Minneapolis,
Minnesota
| – | -$2.89K | -1,710 | Closed |
|
|
PA
157
Parallel Advisors
San Francisco,
California
| – | -$1.69K | -1,000 | Closed |
|